Results 181 to 190 of about 315,615 (312)

A Mouse Model of Depression‐Tumor Multimorbidity Reveals the Mechanism of Tumor Growth Accelerated by Depression

open access: yesAnimal Research and One Health, EarlyView.
Depression accelerates tumor growth by dysregulation of tumor immune microenvironment. (A) Modeling methods: Subcutaneous tumor models were established under chronic unpredictable mild stress conditions, including cold swimming, physical restraint, and food/water deprivation, leading to increased tumor growth.
Yakun Ren   +6 more
wiley   +1 more source

Perceived Discrimination Among Patients With Head and Neck Cancer. [PDF]

open access: yesLaryngoscope Investig Otolaryngol
Hoag TP   +5 more
europepmc   +1 more source

Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective To evaluate the efficacy and safety of guselkumab, an interleukin‐23p19 subunit inhibitor, in participants with active psoriatic arthritis (PsA) and inadequate response (inadequate efficacy and/or intolerance) to one prior tumor necrosis factor (TNF) inhibitor.
Alexis Ogdie   +12 more
wiley   +1 more source

Barriers and Facilitators to Timely Adjuvant Therapy for Head and Neck Cancer in Rural Care. [PDF]

open access: yesJAMA Otolaryngol Head Neck Surg
Wasp GT   +11 more
europepmc   +1 more source

A dose‐finding population pharmacokinetic/pharmacodynamic model of ginisortamab, an anti‐gremlin‐1 monoclonal antibody, in patients with solid tumours

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Ginisortamab, a first‐in‐class human monoclonal antibody for the treatment of advanced solid tumours, binds to gremlin‐1 and restores bone morphogenetic protein signalling. We used pharmacokinetic/pharmacodynamic (PK/PD) modelling to characterize the relationship between ginisortamab dose and serum gremlin‐1 binding, using model‐based simulations ...
Yin Cheong Wong   +6 more
wiley   +1 more source

Interstitial Photodynamic Therapy as Salvage Treatment for Recurrent Head and Neck Cancer

open access: yes, 2009
Interstitial photodynamic therapy ( IPDT) is a technique for applying photodynamic therapy (PDT) to internal tumours using light delivered via fibres inserted percutaneously.
Lou, P-J; Jäger, H R; Jones, L; Theodossy, T; Bown, S G; Hopper, C   +1 more
core  

Healthcare costs in patients with head and neck cancer. [PDF]

open access: yesSupport Care Cancer
Smith J   +3 more
europepmc   +1 more source

Region‐Resolved Proteomics Identifies Molecular Features at the Mucosa‐Polyp Interface in Chronic Rhinosinusitis

open access: yes
International Forum of Allergy &Rhinology, EarlyView.
Yi‐Sook Kim   +7 more
wiley   +1 more source

Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment

open access: yesBMEMat, EarlyView.
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy